Company
Daewon Pharmaceutical Co., Ltd.
Daewon Pharmaceutical Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| DW4421 20mg | Phase 3 | Erosive Reflux Disease |
Latest
No recent events.
Follow Daewon Pharmaceutical Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.